Evidence map›Paper›PMID 27173942›Full record

ArticleNature reviews. Drug discovery2016

Key factors for successful data integration in biomarker research.

Antigoni Elefsinioti, Tanja Bellaire, Albert Wang, Karsten Quast, Henrik Seidel, Michael Braxenthaler, Gernot Goeller, Anastasia Christianson, David Henderson, Joachim Reischl

Abstract read
PubMed Publisher
In one paragraph

Article in Nature reviews. Drug discovery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Translational precision medicine: an industry perspective.Journal of translational medicine · 2021
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Whither systems medicine?Experimental & molecular medicine · 2018
    Review
  7. Empowering pharmacoinformatics by linked life science data.Journal of computer-aided molecular design · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Antigoni ElefsiniotiBayer Pharma AG, Müllerstrasse 178, 13342 Berlin, Germany.
Tanja BellaireBayer Pharma AG, Müllerstrasse 178, 13342 Berlin, Germany.
Albert WangBristol-Myers Squibb, Princeton, New Jersey 08543, USA.
Karsten QuastBoehringer Ingelheim Pharma GmbH &Co. KG, 88397 Biberach an der Riss, Germany.
Henrik SeidelBayer Pharma AG, Müllerstrasse 178, 13342 Berlin, Germany.
Michael BraxenthalerF. Hoffmann-La Roche, New Jersey 10016, USA.
Gernot GoellerBayer Pharma AG, Müllerstrasse 178, 13342 Berlin, Germany.
Anastasia ChristiansonBristol-Myers Squibb, Princeton, New Jersey 08543, USA.
David HendersonBayer Pharma AG, Müllerstrasse 178, 13342 Berlin, Germany.
Joachim ReischlAstraZeneca Personalized HealthCare and Biomarkers, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrating a wide range of biomedical data such as that rapidly emerging from the use of next-generation sequencing is expected to have a key role in identifying and qualifying new biomarkers to support precision medicine. Here, we highlight some of the challenges for biomedical data integration and approaches to address them.

Indexed as

Biomedical ResearchSystems IntegrationBiomarkersData Interpretation, StatisticalHigh-Throughput Nucleotide SequencingHumansMedical InformaticsPrecision MedicineBiomarkers

Identifiers

PMID27173942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.